title: Life-threatening haemorrhage after 750 Le Fort I osteotomies and 376 SARPE procedures.
abstract: This study assessed the incidence, presenting symptoms, diagnosis, and management of patients with life-threatening postoperative haemorrhage after total Le Fort I osteotomy and surgically assisted rapid palatal expansion (SARPE). The medical records of 750 consecutive Le Fort I osteotomies and 376 consecutive SARPEs, both of which involved pterygomaxillary separation with a curved osteotome and a mallet, were analysed prospectively. Two cases of life-threatening haemorrhage were observed in the Le Fort I osteotomy group, both initiated on postoperative day 7. Anterior and posterior nasal packing were successful in one patient; the other required two embolizations for bleeding control (incidence of life-threatening postoperative haemorrhage: 2/750; confidence interval: 0.03-0.96%). In the SARPE group, one brisk epistaxis on the first postoperative day was controlled with anterior and posterior nasal packing under general anaesthesia. This haemorrhage was not considered life threatening (incidence of life-threatening postoperative haemorrhage: 0/376; confidence interval: 0-0.98%). In no case could the source of bleeding be established during re-explorative surgery or during diagnostic arteriography. The authors conclude that life-threatening haemorrhage is an exceptional finding after Le Fort I osteotomy; the observed incidence was 2/750, and life-threatening haemorrhage was not observed after SARPE in this series, despite the use of identical pterygomaxillary separation.
authors.affiliation: Oral and Maxillofacial Surgery, St. John's Hospital, Genk, Belgium. constantinus.politis@uhasselt.be
authors.forename: C
authors.initials: C
authors.lastname: Politis
mesh_terms: D000293:Adolescent; D000792:Angiography / Q000706:statistics & numerical data; D001530:Belgium / Q000453:epidemiology; D004564:Electrocoagulation / Q000706:statistics & numerical data; D004621:Embolization, Therapeutic / Q000706:statistics & numerical data; D004844:Epistaxis / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006488:Hemostasis, Surgical / Q000706:statistics & numerical data; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D008297:Male; D008438:Maxillary Artery / Q000473:pathology; D010027:Osteotomy / Q000009:adverse effects / Q000295:instrumentation / Q000706:statistics & numerical data; D019340:Osteotomy, Le Fort / Q000009:adverse effects / Q000295:instrumentation / Q000706:statistics & numerical data*; D010155:Palatal Expansion Technique / Q000009:adverse effects / Q000706:statistics & numerical data*; D019106:Postoperative Hemorrhage / Q000453:epidemiology*; D011446:Prospective Studies; D056739:Pterygopalatine Fossa / Q000601:surgery; D012086:Reoperation; D012189:Retrospective Studies; D013630:Tampons, Surgical / Q000706:statistics & numerical data; D055815:Young Adult
chemical_list: D006490:Hemostatics